Investor Presentaiton

International Segment A$m Revenue EBITDA-S HY23 HY22 Variance (%) 207.3 156.1 32.8% 123.7 86.2 43.5% EBITDA-S margin 59.7% 55.2% 4.5 pts Transacted Sales 53% 206.4 155.4 32.8% Revenue growth +32.8% 24% 13% 1HCY23 Share of revenue 5% 41% 54% ■China ■African Blue ■Genetics Licensing China African Blue Genetics Licensing Costa well grown 1HCY23 Results Presentation 9

View entire presentation